PMC:7195088 / 30909-31117
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7195088","sourcedb":"PMC","sourceid":"7195088","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7195088","text":"Comparison of siltuximab (anti–IL-6 monoclonal antibody) vs. methylprednisolone in patients with COVID-19. Open-label RCT (NCT04329650, not yet recruiting). Primary endpoint: ICU admission (follow-up 29 days)","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T32","span":{"begin":31,"end":33},"obj":"Body_part"},{"id":"T33","span":{"begin":47,"end":55},"obj":"Body_part"}],"attributes":[{"id":"A32","pred":"fma_id","subj":"T32","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A33","pred":"fma_id","subj":"T33","obj":"http://purl.org/sig/ont/fma/fma62871"},{"subj":"T32","pred":"source","obj":"LitCovid-PD-FMA-UBERON"},{"subj":"T33","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T160","span":{"begin":97,"end":105},"obj":"Disease"}],"attributes":[{"id":"A160","pred":"mondo_id","subj":"T160","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"subj":"T160","pred":"source","obj":"LitCovid-PD-MONDO"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T171","span":{"begin":112,"end":117},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"attributes":[{"subj":"T171","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T414","span":{"begin":31,"end":33},"obj":"Chemical"},{"id":"T416","span":{"begin":61,"end":79},"obj":"Chemical"},{"id":"T417","span":{"begin":112,"end":117},"obj":"Chemical"}],"attributes":[{"id":"A414","pred":"chebi_id","subj":"T414","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A415","pred":"chebi_id","subj":"T414","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A416","pred":"chebi_id","subj":"T416","obj":"http://purl.obolibrary.org/obo/CHEBI_6888"},{"id":"A417","pred":"chebi_id","subj":"T417","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"},{"subj":"T414","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T416","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T417","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T242","span":{"begin":107,"end":156},"obj":"Sentence"},{"id":"T243","span":{"begin":157,"end":208},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T242","pred":"source","obj":"LitCovid-sentences"},{"subj":"T243","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#ec9693","default":true},{"id":"LitCovid-PD-MONDO","color":"#93a9ec"},{"id":"LitCovid-PD-CLO","color":"#c3ec93"},{"id":"LitCovid-PD-CHEBI","color":"#ec93dd"},{"id":"LitCovid-sentences","color":"#93ece0"}]}]}}